INS and Insulin resistance: Metabolic and inflammatory mechanisms contribute to the development of MASH,2,3 with insulin resistance playing a significant role in the pathogenesis of the disease, as reflected by a reduced hepatic, whole body, and adipose tissue insulin sensitivity in this patient population.4